Chemical Component Summary | |
---|---|
Name | KB2115 |
Synonyms | 3-({3,5-dibromo-4-[4-hydroxy-3-(propan-2-yl)phenoxy]phenyl}amino)-3-oxopropanoic acid |
Identifiers | 3-[[3,5-bis(bromanyl)-4-(4-oxidanyl-3-propan-2-yl-phenoxy)phenyl]amino]-3-oxidanylidene-propanoic acid |
Formula | C18 H17 Br2 N O5 |
Molecular Weight | 487.139 |
Type | NON-POLYMER |
Isomeric SMILES | CC(C)c1cc(ccc1O)Oc2c(cc(cc2Br)NC(=O)CC(=O)O)Br |
InChI | InChI=1S/C18H17Br2NO5/c1-9(2)12-7-11(3-4-15(12)22)26-18-13(19)5-10(6-14(18)20)21-16(23)8-17(24)25/h3-7,9,22H,8H2,1-2H3,(H,21,23)(H,24,25) |
InChIKey | VPCSYAVXDAUHLT-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 43 |
Chiral Atom Count | 0 |
Bond Count | 44 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB05035 |
---|---|
Name | Eprotirome |
Groups | investigational |
Description | Eprotirome which is a compound with promising properties for treatment of obesity and dyslipidemia. Eprotirome increases the body’s energy consumption and reduces body weight and markedly reduces blood lipids and blood glucose. |
Synonyms | Eprotirome |
Indication | Investigated for use/treatment in hyperlipidemia, metabolic disease, and obesity. |
Categories |
|
CAS number | 355129-15-6 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Thyroid hormone receptor alpha | MEQKPSKVECGSDPEENSARSPDGKRKRKNGQCSLKTSMSGYIPSYLDKD... | unknown | |
Thyroid hormone receptor beta | MTPNSMTENGLTAWDKPKHCPDREHDWKLVGMSEACLHRKSHSERRSTLK... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL2035874 |
PubChem | 10299876 |
ChEMBL | CHEMBL2035874 |